Soluble terminal complement complex blood levels are elevated in schizophrenia
Authors:
Open Access
- 19 January 2024
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 274 (5) , 1215-1222
Abstract
The role of the complement system in schizophrenia (Sz) is inconclusive due to heterogeneity of the disease and study designs. Here, we assessed the levels of complement activation products and functionality of the classical pathway in acutely ill unmedicated Sz patients at baseline and after 6 weeks of treatment versus matched controls. The study included analyses of the terminal complement complex (sTCC) and C5a in plasma from 96 patients and 96 controls by enzyme-linked immunosorbent assay. Sub-group analysis of serum was conducted for measurement of C4 component and activity of the classical pathway (28 and 24 cases per cohort, respectively). We found no differences in levels of C5a, C4 and classical pathway function in patients versus controls. Plasma sTCC was significantly higher in patients [486 (392–659) ng/mL, n = 96] compared to controls [389 (304–612) ng/mL, n = 96] (p = 0.027, δ = 0.185), but not associated with clinical symptom ratings or treatment. The differences in sTCC between Sz and controls were confirmed using an Aligned Rank Transformation model considering the covariates age and sex (p = 0.040). Additional analysis showed that sTCC was significantly associated with C-reactive protein (CRP; p = 0.006). These findings suggest that sTCC plays a role in Sz as a trait marker of non-specific chronic immune activation, as previously described for CRP. Future longitudinal analyses with more sampling time points from early recognition centres for psychoses may be helpful to better understand the temporal dynamics of innate immune system changes during psychosis development.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01EE2305D)
- Saxony-Anhalt Ministry of Research (I 212)
- Otto-von-Guericke-Universität Magdeburg
This publication has 20 references indexed in Scilit:
- An emerging role for neutrophil extracellular traps in noninfectious diseaseNature Medicine, 2017
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depressionMolecular Psychiatry, 2016
- Schizophrenia risk from complex variation of complement component 4Nature, 2016
- Complement, a target for therapy in inflammatory and degenerative diseasesNature Reviews Drug Discovery, 2015
- C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implicationsMolecular Psychiatry, 2015
- Protein phosphorylation patterns in serum from schizophrenia patients and healthy controlsJournal of Proteomics, 2012
- Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register StudyAmerican Journal of Psychiatry, 2011
- Common variants conferring risk of schizophreniaNature, 2009
- The Complement System in SchizophreniaDrug News & Perspectives, 2008
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999